Literature DB >> 6105907

Comparison of flunitrazepam and thiopentone for induction of general anaesthesia.

J R Maltby, R C Hamilton, R Phillips.   

Abstract

Forty female out-patients undergoing therapeutic abortion participated in a double-blind study comparing flunitrazepam 0.05 mg . kg-1 with thiopentone 6.0 mg . kg-1 as induction agents for general anaesthesia. Induction time, as measured by the time to loss of lid reflex and voluntary speech, was not only significantly longer in patients receiving flunitrazepam, but also much more variable and imprecise than with thiopentone. The Steward recovery room scores and psychomotor drawing test results revealed that recovery was significantly slower in the flunitrazepam group. Anterograde amnesia was observed in all patients who had received flunitrazepam and in one patient who had received thiopentone. No retrograde amnesia was found in either group. Flunitrazepam produced postoperative drowsiness, sedation, ataxia and nausea while with thiopentone discomfort from surgery and discomfort at the intravenous injection site were the main complaints. Because of the slowness of induction with flunitrazepam and marked individual variation, we do not feel that this drug can be considered a suitable agent for routine induction of general anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6105907     DOI: 10.1007/bf03007453

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  13 in total

1.  Local sequelae following the i.v. injection of three benzodiazepines [proceedings].

Authors:  J E Hegarty; J W Dundee
Journal:  Br J Anaesth       Date:  1978-01       Impact factor: 9.166

2.  Clinical studies of induction agents XLIII: Flunitrazepam.

Authors:  J W Dundee; C R Varadarajan; J H Gaston; R S Clarke
Journal:  Br J Anaesth       Date:  1976-06       Impact factor: 9.166

3.  Flunitrazepam compared with althesin as an induction agent in balanced anaesthesia.

Authors:  M A Mattila; P Martikainen; K Säilä
Journal:  Br J Anaesth       Date:  1977-10       Impact factor: 9.166

4.  Anaesthetic induction and maintenance with flunitrazepam.

Authors:  S A Hare
Journal:  S Afr Med J       Date:  1977-09-03

5.  Diazepam and flunitrazepam as induction agents for cardiac surgical operations.

Authors:  R S Clarke; S M Lyons
Journal:  Acta Anaesthesiol Scand       Date:  1977       Impact factor: 2.105

6.  Comparison of diazepam and flunitrazepam for sedation during local anaesthesia for bronchoscopy.

Authors:  K Korttila; L Saarnivaara; J Tarkkanen; J J Himberg; M Hytönen
Journal:  Br J Anaesth       Date:  1978-03       Impact factor: 9.166

7.  [Comparison of the sleep-inducing effect of Ro 5-4200 and nitrazepam].

Authors:  M Schuler; J M Gaillard; R Tissot
Journal:  Psychopharmacologia       Date:  1972

8.  Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations.

Authors:  S A Kaplan; M L Jack; K Alexander; R E Weinfeld
Journal:  J Pharm Sci       Date:  1973-11       Impact factor: 3.534

9.  Intravenous anaesthesia with a new benzodiazepine Ro 5-4200.

Authors:  J Stovner; R Endresen; A Osterud
Journal:  Acta Anaesthesiol Scand       Date:  1973       Impact factor: 2.105

10.  New i.v. anaesthetics.

Authors:  J W Dundee
Journal:  Br J Anaesth       Date:  1979-07       Impact factor: 9.166

View more
  3 in total

Review 1.  Drug-induced cerebellar ataxia: a systematic review.

Authors:  J van Gaalen; F G Kerstens; R P P W M Maas; L Härmark; B P C van de Warrenburg
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

2.  Sedative effects and cardiorespiratory influences of intravenous flunitrazepam premedication.

Authors:  N Suzuki; S Beppu; H Okumura; H Uematsu; T Kondo; Y Kubota
Journal:  Anesth Prog       Date:  1985 May-Jun

Review 3.  Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines.

Authors:  Dorota Olender; Justyna Żwawiak; Lucjusz Zaprutko
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.